Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2. Sep 2008 - Int. J. Oncol.; 33(4):1019-6439 [PMID:18813797] [Janke M] [Peeters B] [Zhao H] [de Leeuw O] [Moorman R] [Arnold A] [Ziouta Y] [Fournier P] [Schirrmacher V]
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy. Jul 2008 - Virus Res.; 136(1-2):0168-1702 [PMID:18538434] [Zhao H] [Janke M] [Fournier P] [Schirrmacher V]
[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte] Aug 2005 - Zhonghua Yi Xue Za Zhi; 85(17):0376-2491 [PMID:16029590] [Zhang HH] [He Y] [Zhao H] [Piao WH] [Liu MC] [Xi HL] [Yu M] [Wang GQ]
